Former Nebraska Senator Ben Sasse has spoken candidly about the visible and painful side effects of the experimental drug he is taking for Stage 4 pancreatic cancer. In a New York Times interview published on 9 April 2026, the 54-year-old father of three detailed how daraxonrasib has caused his skin to break down, leaving his face bloody and feeling as if it has been exposed to nuclear forces.
The treatment, part of a clinical trial, comes after his diagnosis with the aggressive disease in December 2025, which he initially described as a death sentence.
